Robert Cyran, U.S. tech columnist, joined Breakingviews in London in 2003 and moved four years later to New York, where he continues to cover global technology, pharmaceuticals and special situations. Robert began his career at Forbes magazine, where he assisted in the startup of the international version of the magazine. Before working at Breakingviews he worked as a market researcher and reporter covering the pharmaceutical industry. Robert has a Masters degree in economics from Birmingham University and an undergraduate degree from George Washington University.
The hot tech-focused home insurance startup is going public by combining with a blank-check firm backed by the founders of LinkedIn and Zynga. But valuing Hippo’s sales some 60 times more than established rival Allstate’s is as oversized as the mammal it’s named for.
The tech-driven newbie has made a start on disrupting U.S. healthcare. But bigger groups can offer more choice in care, negotiate better prices, and keep more premiums to themselves. Customer growth alone doesn’t make Oscar's 2020 revenue worth more than 10 times rivals' sales.
Pandemic-led demand swings and trade wars have left factories short of semiconductors. The chip industry’s too-successful capital discipline is also a factor. The $450 bln industry’s coming splurge on new capacity will benefit smartphone manufacturers more than automakers.